pH and other effects on the antifungal activity of cilofungin (LY121019)
- PMID: 2751286
- PMCID: PMC172523
- DOI: 10.1128/AAC.33.5.731
pH and other effects on the antifungal activity of cilofungin (LY121019)
Abstract
We investigated the effects of various test conditions on broth macro- and microdilution susceptibility test results for several species of yeasts with a new antifungal agent, cilofungin. As the pH decreased from 7.4 to 3.0, 50% inhibitory concentrations (IC1/2) increased up to 64-fold. This effect was unrelated to yeast growth rate, solvent concentration, or choice of buffer. Broth microdilution results for 42 Candida albicans isolates at pH 7.4 in synthetic amino acid medium, fungal (SAAMF), showed IC1/2 results from 0.08 to 2.5 micrograms/ml, whereas at pH 3.0 the results were 5.0 or 10.0 micrograms/ml. Fungicidal concentrations were closer to MIC results at the lower pH, i.e., an average of 16-fold above the MIC at pH 3.0, compared with an average 256-fold difference at pH 7.4. Two strains that had very different IC1/2 results at pH 7.4 and identical IC1/2 results at pH 3.0 were found to be equally susceptible to cilofungin therapy in rats. In additional studies, other medium effects were demonstrable, with yeast nitrogen broth and minimal essential medium generally yielding higher results than two other synthetic media (SAAMF and RPMI 1640 medium). However, susceptibility results did not change with inoculum between 10(2) and 10(5) yeast cells per ml or temperature between 30 and 37 degrees C. These studies indicate that pH is an important influence on in vitro rank order susceptibility of pathogenic yeasts to cilofungin.
Similar articles
-
Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.Antimicrob Agents Chemother. 1988 Sep;32(9):1331-5. doi: 10.1128/AAC.32.9.1331. Antimicrob Agents Chemother. 1988. PMID: 3058017 Free PMC article.
-
Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.Mycoses. 1989 Mar;32(3):145-50. doi: 10.1111/j.1439-0507.1989.tb02223.x. Mycoses. 1989. PMID: 2733726
-
Susceptibility of Candida species to cilofungin (LY-121019).Mycoses. 1989 Jun;32(6):316-8. doi: 10.1111/j.1439-0507.1989.tb02251.x. Mycoses. 1989. PMID: 2779613
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
[In vitro activity of the echinocandins. How should it be evaluated?].Rev Iberoam Micol. 2005 Sep;22(3):133-40. doi: 10.1016/s1130-1406(05)70026-7. Rev Iberoam Micol. 2005. PMID: 16309347 Review. Spanish.
Cited by
-
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.J Clin Microbiol. 1996 Mar;34(3):489-95. doi: 10.1128/jcm.34.3.489-495.1996. J Clin Microbiol. 1996. PMID: 8904400 Free PMC article. Review.
-
Compounds active against cell walls of medically important fungi.Clin Microbiol Rev. 1993 Jan;6(1):1-21. doi: 10.1128/CMR.6.1.1. Clin Microbiol Rev. 1993. PMID: 8457977 Free PMC article. Review.
-
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.Antimicrob Agents Chemother. 1995 Jul;39(7):1512-6. doi: 10.1128/AAC.39.7.1512. Antimicrob Agents Chemother. 1995. PMID: 7492095 Free PMC article.
-
Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.Antimicrob Agents Chemother. 1997 Sep;41(9):1957-60. doi: 10.1128/AAC.41.9.1957. Antimicrob Agents Chemother. 1997. PMID: 9303393 Free PMC article.
-
Comparison of cilofungin and amphotericin B for therapy of murine candidiasis.Antimicrob Agents Chemother. 1990 Aug;34(8):1619-21. doi: 10.1128/AAC.34.8.1619. Antimicrob Agents Chemother. 1990. PMID: 2221875 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials